Literature DB >> 12379650

Regulation of ionizing radiation-induced Rad52 nuclear foci formation by c-Abl-mediated phosphorylation.

Hiroyuki Kitao1, Zhi-Min Yuan.   

Abstract

The RAD52 epistasis group of proteins, including Rad51, Rad52, and Rad54, plays an important role in the homologous recombination repair of double strand breaks. A well characterized feature associated with the ability of these proteins to repair double strand breaks is inducible nuclear foci formation at the sites of damage. How the process is functionally regulated in response to DNA damage, however, remains elusive. We show here that c-Abl tyrosine kinase associates with and phosphorylates Rad52 on tyrosine 104. Importantly, the very same site of Rad52 is phosphorylated on exposure of cells to ionizing radiation (IR). The functional significance of c-Abl-dependent phosphorylation of Rad52 is underscored by our findings that cells that express the phosphorylation-resistant Rad52 mutant, in which tyrosine 104 is replaced by phenylalanine, exhibit compromised nuclear foci formation in response to IR. Furthermore, IR-induced Rad52 nuclear foci formation is markedly suppressed by the expression of dominant-negative c-Abl. Together our data support a mode of post-translational regulation of Rad52 mediated by the c-Abl tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379650     DOI: 10.1074/jbc.M208151200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Human RAD52 interactions with replication protein A and the RAD51 presynaptic complex.

Authors:  Chu Jian Ma; Youngho Kwon; Patrick Sung; Eric C Greene
Journal:  J Biol Chem       Date:  2017-05-27       Impact factor: 5.157

2.  Rad52 inactivation is synthetically lethal with BRCA2 deficiency.

Authors:  Zhihui Feng; Shaun P Scott; Wendy Bussen; Girdhar G Sharma; Gongshe Guo; Tej K Pandita; Simon N Powell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-08       Impact factor: 11.205

3.  c-Abl downregulates the slow phase of double-strand break repair.

Authors:  V Meltser; M Ben-Yehoyada; N Reuven; Y Shaul
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

Review 4.  Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement.

Authors:  Benjamin H Lok; Simon N Powell
Journal:  Clin Cancer Res       Date:  2012-10-15       Impact factor: 12.531

5.  Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution.

Authors:  Wen-Hsing Cheng; Cayetano von Kobbe; Patricia L Opresko; Kesha M Fields; Jian Ren; Donald Kufe; Vilhelm A Bohr
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  Nucleolar localization and dynamic roles of flap endonuclease 1 in ribosomal DNA replication and damage repair.

Authors:  Zhigang Guo; Limin Qian; Ren Liu; Huifang Dai; Mian Zhou; Li Zheng; Binghui Shen
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

Review 7.  Homologous recombination and its regulation.

Authors:  Lumir Krejci; Veronika Altmannova; Mario Spirek; Xiaolan Zhao
Journal:  Nucleic Acids Res       Date:  2012-03-30       Impact factor: 16.971

8.  Tyrosine phosphorylation enhances RAD52-mediated annealing by modulating its DNA binding.

Authors:  Masayoshi Honda; Yusuke Okuno; Jungmin Yoo; Taekjip Ha; Maria Spies
Journal:  EMBO J       Date:  2011-07-29       Impact factor: 11.598

9.  Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl.

Authors:  Zhihua Jiang; Ravindra Kamath; Shunquian Jin; Manimalha Balasubramani; Tej K Pandita; Baskaran Rajasekaran
Journal:  Mol Cancer       Date:  2011-07-22       Impact factor: 27.401

10.  Recruitment kinetics of DNA repair proteins Mdc1 and Rad52 but not 53BP1 depend on damage complexity.

Authors:  Volker Hable; Guido A Drexler; Tino Brüning; Christian Burgdorf; Christoph Greubel; Anja Derer; Judith Seel; Hilmar Strickfaden; Thomas Cremer; Anna A Friedl; Günther Dollinger
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.